The biggest stories of the day delivered to your inbox.
The biggest stories of the day delivered to your inbox.
CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...
# you may not use this file except in compliance with the License. # You may obtain a copy of the License at # http://www.apache.org/licenses/LICENSE-2.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback